"Significant" changes expected for Medicare

15 January 2007

The White House has leaked proposals for reforming the US Medicare program, as part of President George W Bush's administration target of balancing the federal budget by 2012. Among the plans being discussed are more means-testing for Medicare services and budgetary adjustments to take into account the lower-than-expected costs of the Medicare Part D prescription drug program.

The Financial Times newspaper reports that the Republican administration is trying to portray its proposals as similar to the bipartisan reforms of the social security system, which were a 1997 compromise between the Republican-dominated Congress and the then Democratic President, Bill Clinton.

Part D to cost only $964B for next decade

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight